Lisinopril Tablet
Product Images NDC 51655-335

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 51655-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 335 26 Master Bottle Label Approval Rev A 05 20)

Lisinopril Tablets USP 40 mg label for a bottle containing 90 oral tablets. The label includes storage instructions to protect from light, moisture, freezing, and to store at controlled room temperature. It also advises keeping the product out of reach of children and refers to the package insert for dosage. Labeler is Northwind Health Company, LLC, with NDC 51655-335-26.*

FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical structure of Lisinopril, depicting the molecular arrangement including rings, nitrogen, oxygen, and carbon atoms, with two water molecules indicated (dihydrate form).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.